APA (7th ed.) Citation

Kim, J., Choi, A., Kim, Y. K., & Yoon, S. (2013). Co-treatment with the anti-malarial drugs mefloquine and primaquine highly sensitizes drug-resistant cancer cells by increasing P-gp inhibition. Biochemical & Biophysical Research Communications, 441(3), 655. https://doi.org/10.1016/j.bbrc.2013.10.095

Chicago Style (17th ed.) Citation

Kim, Ju-Hwa, Ae-Ran Choi, Yong Kee Kim, and Sungpil Yoon. "Co-treatment with the Anti-malarial Drugs Mefloquine and Primaquine Highly Sensitizes Drug-resistant Cancer Cells by Increasing P-gp Inhibition." Biochemical & Biophysical Research Communications 441, no. 3 (2013): 655. https://doi.org/10.1016/j.bbrc.2013.10.095.

MLA (9th ed.) Citation

Kim, Ju-Hwa, et al. "Co-treatment with the Anti-malarial Drugs Mefloquine and Primaquine Highly Sensitizes Drug-resistant Cancer Cells by Increasing P-gp Inhibition." Biochemical & Biophysical Research Communications, vol. 441, no. 3, 2013, p. 655, https://doi.org/10.1016/j.bbrc.2013.10.095.